Pancreatic Cancer Research

ResearcherShandong UniversityNo recent work listed

Xinshuang Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9095-3435; OpenAlex author ID A5061014817. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 3

  1. The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer. Last author DOI 10.1177/15330338221142472↗
  2. Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.748442↗
  3. Effect of chemoradiotherapy and neoadjuvant chemoradiotherapy in resectable pancreatic cancer: a systematic review and meta-analysis. Co-author DOI 10.1007/s00432-013-1572-4↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peng Dong · 2 shared papers, 2021–2022 · strength 0.27
  2. Fengjun Liu · 2 shared papers, 2021–2022 · strength 0.27
  3. Sanyuan Hu · 1 shared paper, 2021 · strength 0.13
  4. J. D. Zhang · 1 shared paper, 2014 · strength 0.05
  5. Chunmei Xu · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.